Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Kardium Inc.Updated: Jun 16, 2026Duration: 12 Months
Eligibility criteria

Patients with a planned ablation procedure using the commercially available Glob...

Patients whose life expectancy is 1 year or less [+2]

Read more
Status: Recruiting

Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation

The purpose of this study is to provide clinical data pertaining to the safety and performance of the Globe Mapping and Pulsed Field Ablation System for treating subjects with atrial fibrillation (AF).

Participants needed: 175
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Kardium Inc.Updated: Jan 30, 2026Locations: 1
Eligibility criteria

Subjects planned for an AF catheter ablation procedure, with a documented histor... [+3]

Patients who have contraindications to open heart surgery [+15]

Read more
Status: Recruiting

A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

The study will evaluate the safety and 12-month effectiveness of the Pulmonary Vein Isolation plus Box Isolation of Fibrotic Areas (BIFA) ablation strategy with the Globe Pulsed Field System (Globe PF System) for the treatment of atrial fibrillation.

Participants needed: 115
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Kardium Inc.Updated: Jun 16, 2025Locations: 1
Eligibility criteria

A diagnosis of recurrent symptomatic paroxysmal or persistent AF [+1]

Long-standing persistent AF (sustained >12 months) [+9]

Read more